We hypothesize that themicrobiota/metabolome enterotypes associated to non-TD subtypes may favor the developmentof gut inflammatory environment and gastrointestinal dysfunctions and therefore a more severeα-synucleinopathy. This study adds important information to PD pathogenesis and emphasizes thepotential pathophysiological link between gut microbiota/metabolites and PD motor subtypes
(PDF) Clinical Phenotypes of Parkinson’s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes. Available from: https://www.researchgate.net/publication/348699769_Clinical_Phenotypes_of_Parkinson’s_Disease_Associate_with_Distinct_Gut_Microbiota_and_Metabolome_Enterotypes [accessed Jan 31 2021].